Acorda Therapeutics, Inc. Current Assets
Acorda Therapeutics, Inc. had Current Assets of $48.45 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-05-14
- 2024-03-31: Assets, Current $48.45M.
- 2023-12-31: Assets, Current $74.79M.
- 2023-09-30: Assets, Current $73.73M.
- 2023-06-30: Assets, Current $64.91M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2024-03-31 | $48.45M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $74.79M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $73.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $64.91M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $68.09M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $82.11M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $71.69M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $76.52M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $80.45M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $102.16M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $97.07M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $112.94M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $189.72M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $221.34M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $151.81M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $158.02M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $168.28M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $201.11M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $314.34M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $358.37M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $417.90M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $528.11M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $546.60M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $494.55M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $428.19M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $441.70M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $303.42M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $255.61M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $248.15M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $272.66M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $237.95M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $263.16M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $544.28M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $451.32M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $429.57M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $427.63M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $423.84M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $390.72M 10-K · filed 2016-02-29 | $409.14M 10-K · filed 2015-02-27 |
| 2014-09-30 | $843.89M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $693.13M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $363.42M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $367.33M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $387.80M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $412.90M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $390.88M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $333.06M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $292.83M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $327.24M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $347.71M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $360.94M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $334.37M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $305.85M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $305.68M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $311.17M 10-K · filed 2012-02-28 | $311.17M 10-K · filed 2011-03-01 |
| 2010-09-30 | $299.51M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $263.78M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $293.28M 10-K · filed 2011-03-01 |